How to maximize your drug commercialization investments
The product life cycle solutions you need at every stage.
What’s your vision?
Whether you’re part of a global powerhouse or a one-man show, chances are, you’re an innovator. You want to make the most of scientific advances and move health forward to change patient lives for the better.
We do, too. That’s why we’ve distilled our guidance on what matters most at each stage of the product life cycle into this handy guide to making the most of your commercialization investments — and maximizing product success with a single commercialization partner.
3 out of 4
Biopharma marketing leads are “not very” or only “somewhat” confident they have the right tools, talent, and capabilities to deliver disruptive growth.
50%
Of life sciences commercial leads say they don’t have a good understanding of what their customers want and need.
Step one: pre-clinical and clinical
The choices you make in the early phases of drug development will impact the rest of the journey.
Critical needs at this step:
- Time-sensitive, temperature-controlled logistics
- Reaching eligible patient populations for clinical trials
- Direct-to-patient solutions for remote trial participants
- Data collection and clinical journey insights
- Ability to move treatments across borders
- Comparator sourcing
Success factors at this step:
- Near-perfect execution of storage and transport solutions
- Access to specialty provider networks
- Powerful inventory management, ordering, and tracking tools
- Global reach with local expertise on customs and credentials
- Efficient access to (and transportation of) comparator products
Step two:
pre-launch
Developing your product’s unique value proposition is the next critical step in the commercialization journey, as is defining your distribution channel strategy and designing patient support services.
Position yourself for optimal market access by asking these questions:
- What am I doing to address evidence gaps?
- How will I ensure I have visibility into the ordering process?
- What are my business process and ordering infrastructure needs?
- How am I applying health economics outcomes research (HEOR) to deliver a compelling value story?
- How am I gaining internal consensus on value messages?
- Am I delivering product information where and when payers need it?
- How will I ensure patients can start and stay on therapy with as few barriers as possible?
- How will I educate providers on reimbursement for my therapy?
- Is my product available where patients receive care?
Step three: post-launch and market maturation
The work doesn’t stop once your product launches.
Critical needs at this step:
- Education and support for providers and patients
- Adoption, adoption, adoption
- An action plan for breaking down access barriers
Success factors at this step:
- Innovative solutions from marketing campaigns to targeted education and engagement
- A connection to caregivers where patients present for treatment
- Insight from analytics to refi ne patient support and reimbursement strategies
- Ongoing global distribution excellence